Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ACRZFOTCMKTS:APHQFOTCMKTS:CLABDOTCMKTS:FSDDF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACRZFAcreage$0.00$25.60▼$25.60N/AN/A126,855 shs2,500 shsAPHQFAphria$0.00$5.86▼$19.87$2.89BN/A1.33 million shs1.87 million shsCLABDCore One Labs$0.06+35.6%$0.07$2.00▼$5.00N/AN/A48,295 shs625 shsFSDDFFSD Pharma$6.85-1.3%$6.10$3.43▼$68.66$51.92MN/A11,100 shs36,531 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACRZFAcreage0.00%0.00%0.00%0.00%0.00%APHQFAphria0.00%0.00%0.00%0.00%0.00%CLABDCore One Labs0.00%-25.03%-25.15%+22.55%-56.45%FSDDFFSD Pharma0.00%+13.46%-17.29%+141.64%+1,375.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACRZFAcreageN/AN/AN/AN/AN/AN/AN/AN/AAPHQFAphriaN/AN/AN/AN/AN/AN/AN/AN/ACLABDCore One LabsN/AN/AN/AN/AN/AN/AN/AN/AFSDDFFSD PharmaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACRZFAcreage 0.00N/AN/AN/AAPHQFAphria 0.00N/AN/AN/ACLABDCore One Labs 0.00N/AN/AN/AFSDDFFSD Pharma 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACRZFAcreageN/AN/AN/AN/AN/AN/AAPHQFAphriaN/AN/AN/AN/AN/AN/ACLABDCore One LabsN/AN/AN/AN/AN/AN/AFSDDFFSD Pharma$70K741.76N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACRZFAcreageN/AN/A0.00N/AN/AN/AN/AN/AN/AAPHQFAphriaN/AN/A0.00N/AN/AN/AN/AN/AN/ACLABDCore One LabsN/AN/A0.00∞N/AN/AN/AN/AN/AFSDDFFSD Pharma-$17.52MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACRZFAcreageN/AN/AN/AN/AN/AAPHQFAphriaN/AN/AN/AN/AN/ACLABDCore One LabsN/AN/AN/AN/AN/AFSDDFFSD PharmaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACRZFAcreageN/AN/AN/AAPHQFAphriaN/AN/AN/ACLABDCore One LabsN/AN/AN/AFSDDFFSD PharmaN/A1.811.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACRZFAcreageN/AAPHQFAphria0.14%CLABDCore One LabsN/AFSDDFFSD Pharma0.43%Insider OwnershipCompanyInsider OwnershipACRZFAcreageN/AAPHQFAphriaN/ACLABDCore One LabsN/AFSDDFFSD PharmaN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACRZFAcreageN/AN/AN/ANot OptionableAPHQFAphriaN/A249.75 millionN/ANot OptionableCLABDCore One LabsN/AN/AN/ANot OptionableFSDDFFSD Pharma107.58 millionN/ANot OptionableAPHQF, FSDDF, ACRZF, and CLABD HeadlinesRecent News About These CompaniesFreya Pharma Solutions Strengthens Leadership with Appointment of Distinguished Supervisory BoardJanuary 28, 2025 | markets.businessinsider.comQNTM Quantum BioPharma Ltd.August 31, 2024 | seekingalpha.comHuge Gains, Huge Volume for Biopharma Stock FSD Pharma Inc (NASDAQ: HUGE) (CSE: HUGE)August 10, 2024 | investorideas.comWhat makes FSD Pharma Inc (HUGE) Stock unique?July 22, 2024 | bovnews.comFSD Pharma Inc. (HUGE)May 17, 2024 | finance.yahoo.comWill Earnings Beat Estimates? FSD Pharma Inc (HUGE) StockMay 11, 2024 | bovnews.comFSD Pharma Inc. Obtains Final Order for Plan of ArrangementNovember 27, 2023 | benzinga.comBoth Syneos Health and FSD Pharma claim wins in fight over trial recruitingJuly 19, 2023 | mmm-online.comFSD Pharma gets court complaint alleging breach of nondisclosure agreementMay 12, 2023 | msn.comFirst participant completes dosing in Phase 1 Lucid-MS trialApril 20, 2023 | multiplesclerosisnewstoday.comFSD Pharma Inc Ordinary Shares - Class B (Sub Voting)March 31, 2023 | morningstar.comFSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive DisorderMarch 23, 2023 | benzinga.comFSD Pharma Closes CAD$16.4 Million Sale of Non-Core AssetsMay 10, 2022 | finance.yahoo.comLatest Version of Skyland PIMS® Advances IDBS' Mission to Accelerate BioPharma ManufacturingApril 21, 2022 | finance.yahoo.comAPHQF, FSDDF, ACRZF, and CLABD Company DescriptionsAcreage OTCMKTS:ACRZFAcreage Holdings, Inc. engages in owning and operating cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses. It focuses on the cultivation, processing, and distribution operations. The company was founded by Kevin P. Murphy on July 12, 1989 and is headquartered in New York, NY.Aphria OTCMKTS:APHQFAphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.Core One Labs OTCMKTS:CLABD$0.06 +0.02 (+35.57%) As of 04/25/2025Core One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. Its focus is to bring psychedelic medicines to market through novel delivery systems and psychotherapy. The firm offers isogenics, cultivation, extraction and distillation, consulting, cannastrips, and quality and control. The company was founded on September 14, 2010 and is headquartered in Vancouver, Canada.FSD Pharma OTCMKTS:FSDDF$6.85 -0.09 (-1.30%) As of 04/29/2025FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
